Product
Qutenza
Name
Qutenza
INN Name
capsaicin
FDA Approved
Yes
3 clinical trials
1 organization
7 indications
1 document
Indication
Post Surgical Neuropathic PainIndication
ZostrixIndication
DuloxetineIndication
Peripheral neuropathyIndication
Pulmonary HypertensionIndication
PainClinical trial
An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic PainStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Comparison Between Qutenza and Duloxetine for the Treatment of Painful Chemotherapy-induced Peripheral Neuropathy: a Pragmatic Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Double-blind, Randomized, Crossover Clinical Study to Assess the Efficacy of Qutenza® for the Reduction of Site Pain Caused by Continuous Subcutaneous Infusion of Remodulin®, in Pulmonary Arterial Hypertension PatientsStatus: Completed, Estimated PCD: 2012-07-01
Document
DailyMed Label: QutenzaOrganization
Averitas Pharma Inc